Westfield Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-17,800
Closed -$3.23M – 265
2021
Q1
$3.23M Hold
17,800
– – 0.02% 210
2020
Q4
$3.56M Hold
17,800
– – 0.02% 215
2020
Q3
$3.9M Sell
17,800
-218
-1% -$46.2K 0.03% 206
2020
Q2
$3.44M Sell
18,018
-117,010
-87% -$20.5M 0.02% 208
2020
Q1
$20.9M Sell
135,028
-151,553
-53% -$17.6M 0.18% 139
2019
Q4
$24M Buy
286,581
+16,218
+6% +$1.23M 0.17% 147
2019
Q3
$18.3M Buy
270,363
+7,009
+3% +$461K 0.15% 163
2019
Q2
$17.5M Buy
263,354
+66,774
+34% +$3.89M 0.13% 181
2019
Q1
$10.9M Buy
+196,580
New +$12M 0.08% 196

Other funds holding TDOC

Westfield Capital Management's TDOC Position: Q2 2021 in Review

Westfield Capital Management sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 17,800 shares — an estimated $3.23M sold.

Westfield Capital Management first reported a position in TDOC in Q1 2019 and held it in 9 quarters. The position peaked at $24M in Q4 2019. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Westfield Capital Management reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Westfield Capital Management sold 17,800 Teladoc Health shares in Q2 2021, an estimated $3.23M.
  • Westfield Capital Management first reported a position in Teladoc Health in Q1 2019 and held it in 9 quarters.
  • Westfield Capital Management's Teladoc Health position peaked at $24M in Q4 2019.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Westfield Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.